Medivation (MDVN) Exec Jumps Ship to Become CMO at BeiGene (BGNE)
Bay Area Life Sciences VC Firm Sofinnova Scores $595.5 Million
Facing Public Backlash and Pressure from Clinton, Mylan (MYL) Caves and Lowers Price of EpiPen
AstraZeneca PLC (AZN) Puts 'For Sale' Sign on U.S. HQ
Biotechs are Expanding in the Bay Area Again: Bristol-Myers Squibb (BMY), Genentech (RHHBY), Gilead (GILD), Illumina (ILMN) and Verily and More
Job Cuts Loom as Takeda (TKPYY) to Shutter Cambridge Office and Quits the UK
Mylan (MYL) Isn't Alone: 11 Drug Companies With Muscular Pricing Power and Staggering Profit Margins
What You Don't Know: Pfizer (PFE)’s Connection to Mylan (MYL) and EpiPen
Merck & Co. (MRK)'s Keytruda May Have an Edge Over Bristol-Myers Squibb (BMY)'s Opdivo for Cancer Doctors
Embattled Theranos Plans to Appeal to Re-Open Its Lab in Newark, California
Amidst Dramatic Reorganization, Takeda (TKPYY) May (Or May Not) Shutter Cambridge, UK Site
How Pfizer (PFE)’s Antibiotics Buy from AstraZeneca PLC (AZN) Will Affect Jobs in the U.S.
Led by Former Genentech (RHHBY) Execs, Denali Banks $130 Million, Initiates Trial and Announces a Handful of Partnerships
FDA Slaps Warning on Sun Pharma (SUNPHARMA.NS)'s Former U.S. Facility for Releasing Drug Despite Contamination Issues
Just Days after a $14 Billion Medivation (MDVN) Buy, Pfizer (PFE) Buys AstraZeneca PLC (AZN)'s Antibiotics Business for $1.5 Billion-Plus
Alere (ALR) Drags Abbott (ABT) to Court to Force Completion of $5.8 Billion Deal
Novan Files Paperwork for $60 Million IPO to Develop Skin Drugs
Vanda (VNDA) Investors Elated Over Drug Patent Ruling
See All News >
//-->